Research and development (R & D) into aerospace medicine can be viewed as falling into one of two camps: that aimed at adapting an existing 'terrestrial' medicine for use in the aerospace environment; and that which is newly developed for treating conditions that occur primarily or uniquely in aerospace.
All news from Aviation Medicine & Aerospace Medicine
Nearly two-thirds of people who are at high risk of cardiovascular disease and stroke have excess fat around the middle of the body (central obesity), according to findings from the European Society of Cardiology (ESC) EUROASPIRE V survey.
Rapid drug response screening for leukemia stem cells offers clues to relapse and to improving patient-specific therapies. Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).
Opioids were the cause of more than 42,000 deaths in the US Controlled substances (opioids and other drugs, such as marijuana) pose a threat to both human and environmental health. With the crisis showing no signs of slowing down, officials across the country are scrambling to implement effective intervention programs in their communities.
Tenacious goal pursuit and flexible goal adjustment have been shown to help maintain psychological well-being despite age-related challenges and losses. A recent study demonstrates that tenacity and flexibility are beneficial for out-of-home mobility as well.
The woman arrived at the University of South Florida's navigator office in Tampa a few weeks ago, with a 40-page document describing a short-term health insurance plan she was considering.
She was uncomfortable with what the broker had said about the coverage, she told Jodi Ray, a health insurance navigator who helps people enroll in coverage, and she wanted help understanding it.
A new study published in the journal Arthritis and Rheumatology found that minority of patients with new-onset inflammatory back pain progress to spondyloarthritis, while many resolves. Patients with new-onset inflammatory back pain have just a 30% chance of developing spondyloarthritis during the next 10 years, and a 43% probability of back pain resolution.